Trial description:
Microbiome Immunotherapy Toxicity and Response Evaluation (MITRE) An observational study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy
Contact name:
Dr Pippa Corrie
Trial start date:
Tuesday, March 30, 2021
Trial end date:
Tuesday, December 31, 2024
Trial tumour type:
Kidney
Lung
Skin & melanoma
Show on Radiotherapy:
No
